Augusta University Georgia Patient Treatment — Augusta, Georgia

Augusta University Georgia Patient Treatment is a clinical research site located in Augusta, Georgia, United States 30912.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Augusta University Georgia Patient Treatment has participated in 2 clinical trials.

Therapeutic areas: Sickle Cell Disease (SCD), Paroxysmal Nocturnal Hemoglobinuria (PNH).

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Augusta University Georgia Patient Treatment?

Augusta University Georgia Patient Treatment has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Augusta University Georgia Patient Treatment conducted?

Augusta University Georgia Patient Treatment has 2 clinical trials on record. Their work covers Sickle Cell Disease (SCD), Paroxysmal Nocturnal Hemoglobinuria (PNH).

Is Augusta University Georgia Patient Treatment accredited by Crixeo Health?

Augusta University Georgia Patient Treatment has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Augusta University Georgia Patient Treatment?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.